230 related articles for article (PubMed ID: 19618935)
1. Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro.
Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Carradori S; Granese A; Rivanera D; Frishberg N; Bordón C; Jones-Brando L
J Med Chem; 2009 Aug; 52(15):4574-7. PubMed ID: 19618935
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity.
Tenório RP; Carvalho CS; Pessanha CS; de Lima JG; de Faria AR; Alves AJ; de Melo EJ; Góes AJ
Bioorg Med Chem Lett; 2005 May; 15(10):2575-8. PubMed ID: 15863319
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.
Caputto ME; Ciccarelli A; Frank F; Moglioni AG; Moltrasio GY; Vega D; Lombardo E; Finkielsztein LM
Eur J Med Chem; 2012 Sep; 55():155-63. PubMed ID: 22840495
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids.
de Aquino TM; Liesen AP; da Silva RE; Lima VT; Carvalho CS; de Faria AR; de Araújo JM; de Lima JG; Alves AJ; de Melo EJ; Góes AJ
Bioorg Med Chem; 2008 Jan; 16(1):446-56. PubMed ID: 17905587
[TBL] [Abstract][Full Text] [Related]
5. Quinonic derivatives active against Toxoplasma gondii.
Sarciron ME; Nebois P; Pautet F; Pétavy AF; Fillion H; Walchshofer N
Parasitol Res; 2002 Nov; 88(11):969-71. PubMed ID: 12375161
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.
Carradori S; Secci D; Bizzarri B; Chimenti P; De Monte C; Guglielmi P; Campestre C; Rivanera D; Bordón C; Jones-Brando L
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):746-758. PubMed ID: 28537532
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii.
D'Ascenzio M; Bizzarri B; De Monte C; Carradori S; Bolasco A; Secci D; Rivanera D; Faulhaber N; Bordón C; Jones-Brando L
Eur J Med Chem; 2014 Oct; 86():17-30. PubMed ID: 25140751
[TBL] [Abstract][Full Text] [Related]
8. Tryptanthrin derivatives as Toxoplasma gondii inhibitors--structure-activity-relationship of the 6-position.
Krivogorsky B; Nelson AC; Douglas KA; Grundt P
Bioorg Med Chem Lett; 2013 Feb; 23(4):1032-5. PubMed ID: 23321561
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum.
Baramee A; Coppin A; Mortuaire M; Pelinski L; Tomavo S; Brocard J
Bioorg Med Chem; 2006 Mar; 14(5):1294-302. PubMed ID: 16242338
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles.
Liesen AP; de Aquino TM; Carvalho CS; Lima VT; de Araújo JM; de Lima JG; de Faria AR; de Melo EJ; Alves AJ; Alves EW; Alves AQ; Góes AJ
Eur J Med Chem; 2010 Sep; 45(9):3685-91. PubMed ID: 20541294
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E
J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119
[TBL] [Abstract][Full Text] [Related]
12. A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo.
Shubar HM; Mayer JP; Hopfenmüller W; Liesenfeld O
J Antimicrob Chemother; 2008 May; 61(5):1110-9. PubMed ID: 18285314
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
D'Angelo JG; Bordón C; Posner GH; Yolken R; Jones-Brando L
J Antimicrob Chemother; 2009 Jan; 63(1):146-50. PubMed ID: 18988681
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp.
Chimenti F; Bizzarri B; Maccioni E; Secci D; Bolasco A; Fioravanti R; Chimenti P; Granese A; Carradori S; Rivanera D; Lilli D; Zicari A; Distinto S
Bioorg Med Chem Lett; 2007 Aug; 17(16):4635-40. PubMed ID: 17560783
[TBL] [Abstract][Full Text] [Related]
15. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
De Pablos LM; González G; Rodrigues R; García Granados A; Parra A; Osuna A
J Nat Prod; 2010 May; 73(5):831-4. PubMed ID: 20441162
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of oxime, hydrazone and dichloroacetamide derivatives. Researches of antiparasitic activity].
Berthelot P; Vaccher C; Flouquet N; Viana MN; Savel J; Debaert M
Ann Pharm Fr; 1991; 49(1):31-9. PubMed ID: 1867460
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
Krivogorsky B; Grundt P; Yolken R; Jones-Brando L
Antimicrob Agents Chemother; 2008 Dec; 52(12):4466-9. PubMed ID: 18824607
[TBL] [Abstract][Full Text] [Related]
19. One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii.
Brown CE; Kong T; Bordón C; Yolken R; Jones-Brando L; McNulty J
Bioorg Med Chem Lett; 2018 May; 28(9):1642-1646. PubMed ID: 29598911
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase.
Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
J Med Chem; 2008 Jul; 51(13):3934-45. PubMed ID: 18563892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
